BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

744 related articles for article (PubMed ID: 10950059)

  • 1. Survey of internal medicine residents' use of the fecal occult blood test and their understanding of colorectal cancer screening and surveillance.
    Sharma VK; Corder FA; Raufman JP; Sharma P; Fennerty MB; Howden CW
    Am J Gastroenterol; 2000 Aug; 95(8):2068-73. PubMed ID: 10950059
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Survey of the opinions, knowledge, and practices of gastroenterologists regarding colorectal cancer screening and use of the fecal occult blood test.
    Sharma VK; Corder FA; Fancher J; Howden CW
    Am J Gastroenterol; 2000 Dec; 95(12):3629-32. PubMed ID: 11151904
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Many participants in fecal occult blood test population screening have a higher-than-average risk for colorectal cancer.
    Worthley DL; Smith A; Bampton PA; Cole SR; Young GP
    Eur J Gastroenterol Hepatol; 2006 Oct; 18(10):1079-83. PubMed ID: 16957514
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Colorectal cancer screening and surveillance practices by primary care physicians: results of a national survey.
    Sharma VK; Vasudeva R; Howden CW
    Am J Gastroenterol; 2000 Jun; 95(6):1551-6. PubMed ID: 10894595
    [TBL] [Abstract][Full Text] [Related]  

  • 5. One-time screening for colorectal cancer with combined fecal occult-blood testing and examination of the distal colon.
    Lieberman DA; Weiss DG;
    N Engl J Med; 2001 Aug; 345(8):555-60. PubMed ID: 11529208
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Nonmedical costs of colorectal cancer screening with the fecal occult blood test and colonoscopy.
    Heitman SJ; Au F; Manns BJ; McGregor SE; Hilsden RJ
    Clin Gastroenterol Hepatol; 2008 Aug; 6(8):912-917.e1. PubMed ID: 18534918
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Colorectal cancer screening compliance by medicine residents: perceived and actual.
    Zack DL; DiBaise JK; Quigley EM; Roy HK
    Am J Gastroenterol; 2001 Oct; 96(10):3004-8. PubMed ID: 11693339
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Colorectal cancer screening in Massachusetts: measuring compliance with current guidelines.
    Erban S; Zapka J; Puleo E; Vickers-Lahti M
    Eff Clin Pract; 2001; 4(1):10-7. PubMed ID: 11234181
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Utilization of colorectal cancer screening tests: a 1997 survey of Massachusetts internists.
    Schroy PC; Geller AC; Crosier Wood M; Page M; Sutherland L; Holm LJ; Heeren T
    Prev Med; 2001 Nov; 33(5):381-91. PubMed ID: 11676578
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Improving colorectal cancer screening in a medical residents' primary care clinic.
    Struewing JP; Pape DM; Snow DA
    Am J Prev Med; 1991; 7(2):75-81. PubMed ID: 1910891
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Patient preferences for colorectal cancer screening.
    Leard LE; Savides TJ; Ganiats TG
    J Fam Pract; 1997 Sep; 45(3):211-8. PubMed ID: 9300000
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Colorectal cancer test use--Maryland, 2002-2006.
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 2007 Sep; 56(36):932-6. PubMed ID: 17851446
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Colorectal cancer screening and familial risk: a survey of internal medicine residents' knowledge and practice patterns.
    Barrison AF; Smith C; Oviedo J; Heeren T; Schroy PC
    Am J Gastroenterol; 2003 Jun; 98(6):1410-6. PubMed ID: 12818289
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Barriers to colorectal cancer screening: inadequate knowledge by physicians.
    Gennarelli M; Jandorf L; Cromwell C; Valdimarsdottir H; Redd W; Itzkowitz S
    Mt Sinai J Med; 2005 Jan; 72(1):36-44. PubMed ID: 15682261
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Colorectal cancer: risk factors and recommendations for early detection.
    Read TE; Kodner IJ
    Am Fam Physician; 1999 Jun; 59(11):3083-92. PubMed ID: 10392591
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Screening for colorectal neoplasms with new fecal occult blood tests: update on performance characteristics.
    Allison JE; Sakoda LC; Levin TR; Tucker JP; Tekawa IS; Cuff T; Pauly MP; Shlager L; Palitz AM; Zhao WK; Schwartz JS; Ransohoff DF; Selby JV
    J Natl Cancer Inst; 2007 Oct; 99(19):1462-70. PubMed ID: 17895475
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A cost analysis of screening methodology for family members of colorectal cancer patients.
    Rozen P; Ron E
    Am J Gastroenterol; 1989 Dec; 84(12):1548-51. PubMed ID: 2512809
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Colorectal cancer screening: present strategies and future prospects.
    Marshall JB
    Postgrad Med; 1996 Mar; 99(3):253-64. PubMed ID: 8637834
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A population-based estimate of the extent of colorectal cancer screening in Ontario.
    Rabeneck L; Paszat LF
    Am J Gastroenterol; 2004 Jun; 99(6):1141-4. PubMed ID: 15180738
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Fecal occult blood testing for colorectal cancer screening: use the finger.
    Burke CA; Tadikonda L; Machicao V
    Am J Gastroenterol; 2001 Nov; 96(11):3175-7. PubMed ID: 11721767
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 38.